临床药师对1例美罗培南致婴儿极度血小板增多症的药学干预

Clinical Pharmacist 's Pharmaceutical Intervention to A Case of Severe Thrombocytosis Caused by Meropenem in An Infant

目前引起血小板增多的药物非常少见,但严重血小板增多可引起血栓栓塞风险,可危及患者生命,应引起重视。临床药师针对出生6个月男性患儿在用药过程中出现极度血小板增多症(达1 038×109/L),在病情危急情况下利用自己专业知识,排除疾病等因素,从复杂的用药中判断出美罗培南所致不良反应,并进行了药学干预,避免了不良后果,体现了临床药师的价值。

Few drugs could cause thrombocytosis. However,sever thrombocytosis can cause thrombosis and even cause death,thus special attention should be paid to thrombocytosis. In the case of a 6-month old boy developing a severe thrombocytosis during meropenem treatment course,clinical pharmacists used their professional knowledge to rull out the effect of disease state and identify the adverse effect caused by meropenem out of complexity. Pharmaceutical intervention was given and adverse outcome was prevented.